Curable compositions and membranes

US9238221B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9238221-B2
Application numberUS-201514603477-A
CountryUS
Kind codeB2
Filing dateJan 23, 2015
Priority dateDec 16, 2009
Publication dateJan 19, 2016
Grant dateJan 19, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A curable composition comprising: (i) 2.5 to 50 wt % crosslinker comprising at least two acrylamide groups; (ii) 20 to 65 wt % curable ionic compound comprising an ethylenically unsaturated group and an anionic group; (iii) 15 to 45 wt % solvent; and (iv) 0 to 10 wt % of free radical initiator; wherein the molar ratio of (i):(ii) is 0.1 to 1.5. The compositions are useful for preparing ion exchange membranes.

First claim

Opening claim text (preview).

The invention claimed is: 1. A membrane obtained by a process comprising the following steps: applying a curable composition to a support; and curing the composition to form a membrane; wherein the curable composition comprises: (i) 7.47 to 43.33 wt % crosslinker comprising at least two acrylamide groups; (ii) 20 to 65 wt % curable ionic compound comprising an ethylenically unsaturated group and an anionic group; (iii) 15 to 45 wt % solvent; and (iv) 0 to 10 wt % of free radical initiator; wherein the molar ratio of (i):(ii) is from 0.1 to 1.5. 2. The membrane according to claim 1 wherein (a) the molar ratio of (i):(ii) is from 0.1 to 1.0; (b) the ethylenically unsaturated group is an acrylamide group or a methacrylamide group; and (c) the composition contains 20 to 40 wt % solvent. 3. The membrane according to claim 1 wherein (a) the composition comprises 20 to 40 wt % solvent; (b) the total wt % of components (i) and (ii) relative to the total weight of the composition is 30 to 85 wt %; (c) the solvent comprises at least 40 wt % water; and (d) the molar ratio of (i):(ii) is from 0.13 to 0.7. 4. The membrane according to claim 1 wherein the total wt % of components (i) and (ii) relative to the total weight of the composition is 30 to 85 wt %. 5. The membrane according to claim 1 wherein the solvent comprises at least 40 wt % water. 6. The membrane according to claim 1 wherein the composition comprises 0.005 to 10 wt % photoinitiator. 7. The membrane according to claim 1 wherein the composition is free from ethylenically unsaturated compounds other than components (i) and (ii). 8. The membrane according to claim 1 wherein the curable composition comprises: (i) 8 to 16 wt % crosslinker comprising at least two acrylamide groups; (ii) 40 to 60 wt % curable ionic compound comprising an ethylenically unsaturated group and an anionic group; (iii) 22 to 40 wt % solvent; and (iv) 0.01 to 2 wt % of photoinitiator; wherein the molar ratio of (i):(ii) is from 0.1 to 1.0. 9. The membrane according to claim 1 wherein the curing is performed using electron beam or UV radiation. 10. The membrane according to claim 1 wherein the composition is cured by irradiation with an electron beam or UV light for a period of less than 30 seconds. 11. The membrane according to claim 1 wherein the curable composition is applied continuously to a moving support using a manufacturing unit comprising a curable composition application station, an irradiation source for curing the composition, and a membrane collecting station and wherein the support moves from the curable composition application station to the irradiation source and to the membrane collecting station. 12. The membrane according to claim 8 wherein the curing is performed using electron beam or UV radiation. 13. The membrane according to claim 8 wherein the composition is cured by irradiation with an electron beam or UV light for a period of less than 30 seconds.

Assignees

Inventors

Classifications

  • Capacitive deionisation · CPC title

  • containing oxygen in addition to the carbonamido oxygen {, e.g. N-methylolacrylamide, N-(meth)acryloylmorpholine} · CPC title

  • by ion-exchange (ion-exchange in general B01J) · CPC title

  • Dialytic cells or batteries; Reverse electrodialysis cells or batteries · CPC title

  • Electrolytic cell with membranes or diaphragms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9238221B2 cover?
A curable composition comprising: (i) 2.5 to 50 wt % crosslinker comprising at least two acrylamide groups; (ii) 20 to 65 wt % curable ionic compound comprising an ethylenically unsaturated group and an anionic group; (iii) 15 to 45 wt % solvent; and (iv) 0 to 10 wt % of free radical initiator; wherein the molar ratio of (i):(ii) is 0.1 to 1.5. The compositions are useful …
Who is the assignee on this patent?
Fujifilm Mfg Europe Bv
What technology area does this patent fall under?
Primary CPC classification B01J39/20. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).